Friday, August 14, 2026

Metavia Highlights Strong Early Weight-Loss Data for DA-1726 at EASL 2026

MetaVia's obesity treatment candidate 'DA-1726' shows safety and weight loss effects in Phase 1 trials after 54 days.

Tag: SeAH Steel

No posts to display

Top News

- Our Sponsors Ad -

Follow us